Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
GlobeNewswire
SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Raydiant Oximetry, Inc., a clinical-stage medical device company that..
SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Raydiant Oximetry, Inc., a clinical-stage medical device company that..
ViewThey are the most vulnerable patients, and their care is being called into question.
"Moms and babies are..
Access to pregnancy and birth care for American women is dwindling across the country, particularly in rural areas, according to a..